Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9Thoracic 3NET 2Gynecologic 2Endocrine 2Sarcoma 1Head & Neck 1Dermatologic 1CNS 1Breast 1

Conditions

Melanoma 390Skin Neoplasms 90Carcinoma, Non-Small-Cell Lung 79Breast Neoplasms 56Neoplasms 55Colorectal Neoplasms 53Lung Neoplasms 52Neoplasm Metastasis 46Ovarian Neoplasms 44Lymphoma, T-Cell, Cutaneous 44Carcinoma, Renal Cell 43Squamous Cell Carcinoma of Head and Neck 42Uveal Melanoma 39Pancreatic Neoplasms 38Sarcoma 36Carcinoma, Basal Cell 36Head and Neck Neoplasms 33Uterine Cervical Neoplasms 32Prostatic Neoplasms 32Stomach Neoplasms 31Carcinoma, Merkel Cell 30Carcinoma, Hepatocellular 30Endometrial Neoplasms 29Urinary Bladder Neoplasms 28Kidney Neoplasms 26Triple Negative Breast Neoplasms 24Esophageal Neoplasms 22Carcinoma, Squamous Cell 22Lymphoma 20Mycosis Fungoides 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Intestinal Neoplasms × Dermatologic × Clear all
NCT05379985 2026-05-15

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Revolution Medicines, Inc.

Phase 1/2 Recruiting
754 enrolled
DermatologicGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplastic Processes, Pancreatic Neoplasms, Thoracic Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡